Search clinical trials for: adenosine agonist

Total 14545 results

Timothy M. Bateman, MD

Completed

Characterization of Myocardial Blood Flow Measurements Using Lexiscan®™ (Regadenoson) (Lexiscan®™) Rubidium-82 Myocardial Perfusion PET: A Temporal-Dependency Investigation

Myocardial Blood Flow Reserve

United States
Washington University School of Medicine
Astellas Pharma US, Inc.

Completed

Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson (PET/MR-P)

Ischemic Heart Disease

United States
Assiut University

Unknown

Management of Supraventricular Tachycardia of Children

Supraventricular Tachycardia
Ochsner Health System
Astellas Pharma Global Development, Inc.

Completed

Intravenous Regadenoson Versus Intravenous Adenoscan® for Fractional Flow Reserve (FFR)

Coronary Artery Disease

United States
University Medical Center Groningen

Terminated

Non-invasive and Invasive Assessment of Coronary Artery Disease (COMFORT)

Coronary Artery Disease

Netherlands, Sweden
Cedars-Sinai Medical Center
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Completed

Contrast- Enhanced Whole-Heart Coronary MRA at 3.0T (Tesla)

Coronary Artery Disease

United States
Vanderbilt University

Terminated

Role of Adenosine in the Release of VEGF and Cytokines

Inflammation

United States
Vanderbilt University

Completed

Effect of Ticagrelor vs. Dipyridamole on Adenosine Uptake

Coronary Artery Disease

United States
Inotek Pharmaceuticals Corporation

Completed

Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG

Ocular Hypertension (OHT) | Primary Open-Angle Glaucoma (POAG)

United States
Columbia University

Completed

Analysis of Adenosine on Sinus and Atrioventricular Nodal Conduction in the Pediatric Transplanted Heart

Atrioventricular Block | Sinus Bradycardia

United States
Dana-Farber Cancer Institute
Johns Hopkins University; Baylor College of Medicine; Washington University School... and other collaborators

Completed

A Phase II Trial of Regadenoson in Sickle Cell Anemia

Sickle Cell Anemia

United States
University of Utah

Completed

Muscle Afferent Feedback Effects in Patients With Heart Failure

Chronic Heart Failure

United States
Alexandrovska University Hospital

Unknown

Pharmacologic Treatment of Myocardial Ischemia Detected by Intracoronary ECG

Coronary Ischemia

Bulgaria
Astellas Pharma Inc

Completed

A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)

Coronary Artery Disease (CAD)

United States
Astellas Pharma Inc

Completed

Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

Coronary Artery Disease (CAD)

United States
University of Michigan

Completed

Adenosine to Assess Complete Conduction Block During Catheter Ablation of Paroxysmal Atrial Fibrillation

Atrial Fibrillation

United States
University of Utah

Completed

Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients (RECAD-AF)

Coronary Artery Disease | Atrial Fibrillation

United States
Inotek Pharmaceuticals Corporation

Completed

A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma

Ocular Hypertension (OHT) | Primary Open-Angle Glaucoma (POAG)

United States
Menoufia University

Completed

Adenosine and Magnesium Sulphate as Adjuvants for PECS Block.

Breast Surgery
Turku University Hospital
University of Bonn

Completed

Adenosine and A2A Receptors in Human Brown Adipose Tissue (AdenoBAT)

Obesity
Medical College of Wisconsin

Completed

Validation Durability Adenosine Effect in Verification Pulmonary Vein Isolation

Atrial Fibrillation

United States
Dipan Shah
Astellas Pharma Global Development, Inc.

Unknown

Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease

Coronary Artery Disease

United States
National Cancer Institute (NCI)

Completed

Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer

Renal Cell Carcinoma | Graft-Versus-Host Disease | Engraftment Syndrome

United States
Bryan Goldstein

Completed

Coronary Artery Vasculopathy in Pediatric Heart Transplant Patients (CFR-OHT)

Orthotopic Heart Transplant

United States
Paul Kim
Astellas Pharma Inc

Completed

Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction

Acute Graft Rejection | Heart Transplant | Chronic Graft Rejection

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Astex Pharmaceuticals, Inc.

Completed

Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia

Lymphoma | Leukemia

United States
Sejong General Hospital

Unknown

Hyperemic Efficacy of IV Adenosine in HFrEF (HF-FFR)

Coronary Artery Disease | Heart Failure With Reduced Ejection Fraction

Korea, Republic of
St. Louis University
Astellas Pharma US, Inc.; University of Florida

Completed

Comparison of Intravenous Adenosine Infusion With Regadenoson Bolus for Inducing Maximal Coronary Hyperemia

Coronary Artery Disease

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Lymphoma | Leukemia

United States
GlaxoSmithKline

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intravenous Infusion of GW328267X in Healthy Volunteers

Lung Injury, Acute

United Kingdom
Assiut University

Unknown

Gene Study for Infantile Onset Diabetes

Study Genetic Basis of Infantile Onset Diabetes Mellitus
University of Cincinnati

Completed

Anti-gravity Treadmill Exercise in Stress Myocardial Perfusion Imaging

Coronary Artery Disease

United States
Yong Seog Oh

Completed

Adenosine Effect on Persistent Pulmonary Vein Isolation Line Evaluation (APPLE Trial) (APPLE)

Atrial Fibrillation | Persistent Common Pulmonary Vein

Korea, Republic of
Amphia Hospital

Unknown

Adenosine as an Adjunct to Blood Cardioplegia

Cardiomyopathies | Pathological Processes

Netherlands
Freeman-Sheldon Research Group, Inc.

Terminated

Study of Quality of Life in Freeman-Sheldon Syndrome and Related Conditions (FSS-QLS)

Depressive Disorder | Craniofacial Abnormalities | Posttraumatic Stress Disorder | Arthrogryposis

United States, Guatemala
Sara Varea

Completed

ATP in Alzheimer Disease

Alzheimer's Disease

Spain
University of Aarhus

Unknown

The Effect of A2A Adrenoceptor Stimulation on the Diameter of Retinal Arterioles During Hypoxia in Vivo

Retinal Artery Occlusion

Denmark
University of Pittsburgh

Completed

Dexmedetomidine and Adenosine: Therapeutic Use for SVT

Supraventricular Tachycardia

United States
Singapore General Hospital

Completed

Effectiveness of Calcium Channel Blockers and Adenosine in the Emergency Management of SVT

Supraventricular Tachycardia

Singapore
Ohio State University Comprehensive Cancer Center
Astex Pharmaceuticals, Inc.

Completed

Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic Leukemia

B-Chronic Lymphocytic Leukemia

United States
University of Patras

Completed

Differential Effect of High (200μg/kg/Min) Adenosine Dose on Fractional Flow Reserve in Patients Presenting Variation of FFR ≥0.05 During the Usual Dose of Adenosine Infusion (140μg/kg/Min).

Coronary Artery Disease

Greece
Niguarda Hospital
GlaxoSmithKline; Hospira, now a wholly owned subsidiary of Pfizer; Regione Lombardia

Completed

Trial of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) in Older Patients With Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

Italy
Inotek Pharmaceuticals Corporation

Completed

Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma (MATrX-1)

Ocular Hypertension (OHT) | Primary Open-Angle Glaucoma (POAG)

United States
US Oncology Research
Astex Pharmaceuticals, Inc.

Completed

Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients

B-Cell Chronic Lymphocytic Leukemia

United States
Maastricht University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

Application of ATP Infusions in Palliative Home Care

Quality of Life | Cancer | Palliative Care | Survival

Netherlands
Noblewell
Cibiem, Inc.

Completed

Study on Reflex Response During Temporary Stimulation and Inhibition of Chemoreceptors of Carotid Bodies - a Pilot Study

Heart Failure | Peripheral Chemoreceptor Hypersensitivity

Poland
M.D. Anderson Cancer Center
National Cancer Institute (NCI); FDA Office of Orphan Products Development

Completed

8-Chloro-Adenosine in Chronic Lymphocytic Leukemia

Leukemia | Chronic Lymphocytic Leukemia

United States
Central Hospital, Nancy, France

Unknown

Role and Interactions of Adenosine, Receptors, Methionine Cycle Nutritional, Metabolic and Genetic Determinants in the Onset of Atrial Fibrillation in Normal Heart (FACS)

Atrial Fibrillation

France
The University of Texas Health Science Center,...
Abbott Medical Devices

Completed

CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTing Physiology?) (CONTRAST)

Coronary Artery Disease

Korea, Republic of, Italy, Sweden, United States, Belgium, France, Netherlands, Portugal, United Kingdom
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer

Lymphoma | Leukemia

United States

Search clinical trials for: adenosine agonist

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations